Publication | Closed Access

A novel liposomal irinotecan formulation with significant anti-tumour activity: Use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention

Lipid PreparationNanomedicineCopper-containing LiposomesPharmaceutical ScienceMedicineDrug RetentionPharmacotherapyAnti-cancer AgentTumor TargetingPharmacologyRadiation OncologySignificant Anti-tumour ActivityDrug Discovery